Surgical Liver Therapy
Liver Transplantation (LTx) has become an accepted clinical method in cases of end-stage or fatal acute liver diseases. The majority of LTx are performed orthotopically. Heterotopic transplantations are reserved for special indications like acute liver failure and metabolic diseases. The shortage of donor organs - 17.000 patients are currently on the transplant waiting list in the US alone - lead to the development of techniques like transplantation of reduced-size organs, transplantation of "split-livers" and living-related LTx. 2007 around 11.000 to 13.000 LTx were performed worldwide.
Liver resection is the standard treatment for hepatocellular carcinoma, but it can only be used for 5-15% of the patients. There are about 1 Million new cases each year worldwide and without medical treatment the death rate would be 100%.Since other non-surgical techniques like ablation and chemotherapy offer 5-year-survival rates of 30-40%, an estimated 550,000 people each year die of liver cancer. Outside of the West, the survival rate is much lower and about 360,000 deaths each year are from countries in Eastern Asia alone, which makes liver cancer one of the top three causes of death by cancer in most of Asia.
Contact us regarding "Surgical Liver Therapy"
or call Tilo Stolzke at +49 451 400 83 01 directly.